PDL-1 in non-small cell lung cancer (NSCLC): Association with molecular alterations and clinical outcome
Integrating clinical, molecular, and immunological data will enhance the predictive value of PDL-1 biomarkers in lung adenocarcinoma.
Authors
- Daphne Fonseca (ORCID: https://orcid.org/0000-0002-6209-4765)
- Sahithi Shilpa Arya (ORCID: https://orcid.org/0000-0003-4604-3009)
- Khalid Abdul Mannan (ORCID: https://orcid.org/0000-0002-3255-541X)
- Suseela Kodandapani (ORCID: https://orcid.org/0000-0003-1798-9188)
- Senthil Jagannathan Rajappa (ORCID: https://orcid.org/0000-0002-5597-756X)
- K.I.S.N. Vaishnavi (ORCID: https://orcid.org/0009-0009-1358-802X)
Institutions
- Basavatarakam Indo American Cancer Hospital and Research Institute (IN)
Publication Details
- Journal
- Indian Journal of Cancer
- Published
- 2025-04-01
- DOI
- https://doi.org/10.4103/ijc.ijc_151_23
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00